loading

Adverum Biotechnologies Inc Azioni (ADVM) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - 1.00 -
Operating Expenses
3.39%
49.85
48.22 42.62 35.44 32.90
Depreciation and Amortization
21.67%
0.535
0.683 0.81 0.89 0.956
Operating Income/Loss
3.39%
-49.85
-48.22 -42.62 -34.44 -32.90
Income/Loss From Continuing Operations Before Tax
4.62%
-49.19
-47.02 -60.53 -27.13 -18.48
Income/Loss From Continuing Operations After Tax
4.62%
-49.19
-47.02 -40.93 -32.35 -30.50
Net Income/Loss
4.62%
-49.19
-47.02 -40.93 -32.35 -30.50
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.34%
21.01
20.94 0.374 20.88 20.85
Diluted Average Shares
0.34%
21.01
20.94 0.374 20.88 20.85
Basic Earnings Per Share
4.00%
-2.34
-2.25 -1.98 -1.55 -1.46
Diluted Earnings Per Share
4.00%
-2.34
-2.25 -1.98 -1.55 -1.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.71
price up icon 0.10%
$106.77
price up icon 0.59%
$116.62
price up icon 8.60%
$99.59
price up icon 0.55%
biotechnology ONC
$331.62
price up icon 2.72%
$183.80
price up icon 7.25%
Capitalizzazione:     |  Volume (24 ore):